(duplicate) Tuberous Sclerosis Complex Registry Study (TOSCA)

  • Research type

    Research Database

  • Full title

    An international disease registry collecting data of manifestations, interventions and outcomes in patients with tuberous sclerosis complex

  • IRAS ID

    234691

  • Contact name

    Eduardo Chicote

  • Contact email

    eduardo.chicote@novartis.com

  • Clinicaltrials.gov Identifier

    REC Number, 12/WA/0159 ; IRAS number, 106630

  • Duration of Study in the UK

    8 years, 6 months, 25 days

  • Research summary

    Tuberous Sclerosis Complex Registry Study (TOSCA)

  • REC name

    Wales REC 5

  • REC reference

    18/WA/0013

  • Date of REC Opinion

    22 Jan 2018

  • REC opinion

    Favourable Opinion

  • Data collection arrangements

    Following collection of informed consent, patients with TSC and, where applicable, their parents will provide a medical history, including prenatal, genotyping family history, current disease features and manifestations, comorbidities, mTOR treatment details and other treatments and surgical procedures. DAta from samples biopsies, scans, neurocognition tests, and other assessments and procedures collected in the course of the patient routine clinical care will be used, but no procedures will be performed for the purpose of the trial. Patients will be followed up in accordance with standard medical practice and at least once every 12 months. The registry information will be updated on the basis of these follow up visits over a period of up to 6.5 years. Data from approximately 1000 patients with TSC throughout Europe will be collected and entered into the database using 21 CRF Part 11 complaint processes. The disease registry data will be stored in a secure database in the offices of Novartis Pharma AG in Switzerland.

  • Research programme

    The TSC community will benefit from the better understanding of their disease and its treatment that will be gained from the data analysis and future research of this disease registry.

  • Research database title

    Tuberous Sclerosis Complex Registry Study (TOSCA)

  • Establishment organisation

    Novartis Pharmaceuticals AG

  • Establishment organisation address

    Novartis Campus

    Switzerland

    CH4056